Bloomberg TalksBloomberg Talks

Teva CEO Talks Drug Pricing, Generics, Supply Shortages

View descriptionShare

Teva Pharmaceuticals CEO Richard Francis reflects on company performance in 2024, drug pricing, getting more drugs to market and supply shortages of the drug Adderall.

He speaks to Bloomberg's Katie Griefeld from the JPMorgan Healthcare Conference.

 
  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Bloomberg Talks

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in financ 
Social links
Follow podcast
Recent clips
Browse 2,674 clip(s)